These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8453165)

  • 1. Arthropathy secondary to ciprofloxacin in an adult cystic fibrosis patient.
    Samuelson WM; Pleasants RA; Whitaker MS
    Ann Pharmacother; 1993 Mar; 27(3):302-3. PubMed ID: 8453165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging in children receiving quinolones: no evidence of quinolone-induced arthropathy. A multicenter survey.
    Danisovicová A; Brezina M; Belan S; Kayserová H; Kaiserová E; Hruskovic I; Orosová K; Dluholucký S; Galova K; Mathéova E
    Chemotherapy; 1994; 40(3):209-14. PubMed ID: 8205939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, radiologic and magnetic resonance monitoring for skeletal toxicity in pediatric patients with cystic fibrosis receiving a three-month course of ciprofloxacin.
    Schaad UB; Stoupis C; Wedgwood J; Tschaeppeler H; Vock P
    Pediatr Infect Dis J; 1991 Oct; 10(10):723-9. PubMed ID: 1945573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheumatologic aspects of pediatric cystic fibrosis patients treated with fluoroquinolones.
    Warren RW
    Pediatr Infect Dis J; 1997 Jan; 16(1):118-22; discussion 123-6. PubMed ID: 9002121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ciprofloxacin use: acute arthropathy and long-term follow up.
    Karande S; Kshirsagar NA
    Indian Pediatr; 1996 Nov; 33(11):910-6. PubMed ID: 9141825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic fibrosis and drug-induced arthropathy.
    Jawad AS
    Br J Rheumatol; 1989 Apr; 28(2):179-80. PubMed ID: 2706427
    [No Abstract]   [Full Text] [Related]  

  • 7. Arthropathy and cutaneous manifestations in a 28-year-old patient with cystic fibrosis.
    Lampert S; Schahin SP; Wiest GH; Hahn EG; Ficker JH
    Monaldi Arch Chest Dis; 2006 Jun; 65(2):114-5. PubMed ID: 16913584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arthropathy in a patient with cystic fibrosis taking ciprofloxacin.
    Alfaham M; Holt ME; Goodchild MC
    Br Med J (Clin Res Ed); 1987 Sep; 295(6600):699. PubMed ID: 3117310
    [No Abstract]   [Full Text] [Related]  

  • 9. Quinolone-induced arthropathy in the neonatal mouse. Morphological analysis of articular lesions produced by pipemidic acid and ciprofloxacin.
    Linseman DA; Hampton LA; Branstetter DG
    Fundam Appl Toxicol; 1995 Nov; 28(1):59-64. PubMed ID: 8566484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On fluoroquinolones treatment safety in children (clinical, morphological and catamnesis data)].
    Postnikov SS; Semykin SIu; Nazhimov VP; Novichkova GA
    Antibiot Khimioter; 2002; 47(9):14-7. PubMed ID: 12619515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability and pharmacokinetic properties of ciprofloxacin dry powder for inhalation in patients with cystic fibrosis: a phase I, randomized, dose-escalation study.
    Stass H; Weimann B; Nagelschmitz J; Rolinck-Werninghaus C; Staab D
    Clin Ther; 2013 Oct; 35(10):1571-81. PubMed ID: 24054830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral ciprofloxacin in the treatment of pseudomonas exacerbations of paediatric cystic fibrosis: clinical efficacy and safety evaluation using magnetic resonance image scanning.
    Redmond A; Sweeney L; MacFarland M; Mitchell M; Daggett S; Kubin R
    J Int Med Res; 1998 Dec; 26(6):304-12. PubMed ID: 10399112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute reversible arthropathy in a pediatric patient with cancer treated with a short course of ciprofloxacin for febrile neutropenia.
    Mullen CA; Petropoulos D; Rytting M; Jeha S; Zipf T; Roberts WM; Rolston KV
    J Pediatr Hematol Oncol; 1998; 20(5):516-7. PubMed ID: 9787333
    [No Abstract]   [Full Text] [Related]  

  • 14. Ciprofloxacin-induced renal insufficiency in cystic fibrosis.
    Moffett BS; Rosenstein BJ; Mogayzel PJ
    J Cyst Fibros; 2003 Sep; 2(3):152-4. PubMed ID: 15463865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ciprofloxacin therapy in cystic fibrosis.
    Scully BE; Nakatomi M; Ores C; Davidson S; Neu HC
    Am J Med; 1987 Apr; 82(4A):196-201. PubMed ID: 3555036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased oral bioavailability of ciprofloxacin in cystic fibrosis patients.
    Christensson BA; Nilsson-Ehle I; Ljungberg B; Lindblad A; Malmborg AS; Hjelte L; Strandvik B
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2512-7. PubMed ID: 1489195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ciprofloxacin: an alternative oral treatment in respiratory Pseudomonas infection in cystic fibrosis].
    Magni A; Pradal U; Cazzola G; Mastella G
    Pediatr Med Chir; 1990; 12(5):531-4. PubMed ID: 2087426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: III. fluoroquinolones.
    Stockmann C; Sherwin CM; Zobell JT; Young DC; Waters CD; Spigarelli MG; Ampofo K
    Pediatr Pulmonol; 2013 Mar; 48(3):211-20. PubMed ID: 22949224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of quinolones in the treatment of Pseudomonas aeruginosa infections in children with cystic fibrosis].
    Milio MC; Campana S
    Pediatr Med Chir; 1995; 17(1):53-5. PubMed ID: 7739928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of ciprofloxacin in children with cystic fibrosis.
    Orenstein DM; Pattishall EN; Noyes BE; Kurland G; Hartigan ER; Yu VL
    Clin Pediatr (Phila); 1993 Aug; 32(8):504-6. PubMed ID: 8403750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.